Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 2, 2006, Pages 213-221

  Soorapanth, Sada ^a,d   Sansom, Stephanie ^a   Bulterys, Marc ^a   Besser, Mitchell ^b   Theron, Gerhard ^c   Fowler, Mary Glenn ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Cost effectiveness analysis; HIV rescreening; Perinatal HIV prevention

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; PARAMETER; PERINATAL INFECTION; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SOUTH AFRICA; VERTICAL TRANSMISSION;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MASS SCREENING; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUALITY-ADJUSTED LIFE YEARS; SOUTH AFRICA; ZIDOVUDINE;

EID: 33745071477     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000214812.72916.bc     Document Type: Article

References (49)

1. UNAIDS/WHO. AIDS epidemic update: November 21, 2005. Available at: http://www.unaids.org/epi/2005.
2. Preventing mother-to-child transmission of HIV. AVERT 2005. Available at: http://www.avert.org/motherchild.htm.
3. Venter C. Big rise in child mortality rate in SA. Health Systems Trust News 2004-11-04. Available at: http://www.hst.org.za/news/20040558.
4. Q&A I: Basic facts about the AIDS epidemic and its impact. UNAIDS Questions & Answers, November 2005.
5. The impact of HIV & AIDS on Africa. AVERT 2005. Available at: http://www.avert.org/aidsimpact.htm.
6. Maclean C, Stringer J. Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding. J Acquir Immune Defic Syndr. 2005;38:570-577.
7. Sansom SL, Jamieson DJ, Farnham PG, et al. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet Gynecol. 2003;102:782-790.
8. Skordis J, Nattrass N. Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa. J Health Econ. 2002;21:405-421.
9. Stringer JSA, Rouse DJ, Vermund SH, et al. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2000;24:369-377.
10. Marseille E, Kahn JG, Mmiro F, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999;354:803-809.
11. Soderlund N, Zwi K, Kinghorn A, et al. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ. 1999;318:1650-1657.
12. Mansergh G, Haddix A, Steketee R, et al. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA. 1996; 276:139-145.
13. Pregnancy and HIV/AIDS. WHO Fact Sheet No. 250, June 2000. Available at: http://www.who.int/mediacentre/factsheets/fs250/en/.
14. De Cock KM, Marum E, Mbori-Ngacha D. A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet. 2003; 362:1847-1849.
15. Antiretroviral treatment of HIV infection in infants and children in resource-limited settings, towards universal access: recommendations for a public health approach [draft]. 2005 Revision; October 2005. Available at: http://www.who.int/hiv/pub/guidelines/arv/en/index.html.
16. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005; 366:1182-1188.
17. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
18. Lallemant M, Jourdain G, Le Coeur S, et al. for the Perinatal HIV Prevention Trial (Thailand) Investigators. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
19. Haddix AC, Teutsch SM, Corso PS eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation, 2nd ed. New York, NY: Oxford University Press, 2003.
20. South Africa's Consumer Price Index (CPI). Statistics South Africa. Available at: www.statssa.gov.za.
21. FXHistory: historical currency exchange rates. Available at: http://www.oanda.com/convert/fxhistory.
22. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr. 1997; 16:54-62.
23. Cartoux M, Meda N, Van de Perre P, et al. and the Ghent International Working Group on Mother-to-child Transmission of HIV. Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. AIDS. 1998; 12:2489-2493.
24. Geffen N, Nattrass N, Raubenheimer C. The cost of HIV prevention and treatment interventions in South Africa. Centre for Social Science Research Working Paper No. 28. University of Cape Town. 2003. Available at: http://www.uct.ac.za/dept/cssr/pubs.html.
25. Jackson JB, Musoke P, Flemming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18 month follow-up of the HIVNET 012 randomised trial. Lancet. 2003; 362:859-868.
26. Vanprapar N, Chotpitayasunondh T, Culnane M, et al. Infant ARV prophylaxis failures from a study of a short-course zidovudine plus 2-dose nevirapine regimen for prevention of mother-to-child HIV transmission in Thailand. Presented at: XV International AIDS Conference; 2004; Bangkok, Thailand. Abstract ThPeB7080.
27. Dabis F, Ekouevi DK, Bequet L, Rouet F, et al. ANRS PACCI DITRAME Plus Study Group. A short course of zidovudine + peripartum nevirapine is highly efficacious in preventing mother-to-child transmission of HIV-1: The ANRS 1201 DITRAME-plus study, Abidjan, Cote d'Ivoire. Presented at: The 10th Conference on Retroviruses and Opportunistic Infections; 2003; Boston, MA, USA. Poster abstract number 854.
28. Newell ML, Coovadia H, Cortina-Borja M, et al. for the Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004; 364:1236-1243.
29. WHO bulk procurement scheme 2004, World Health Organization. Available at: http://www.who.int/3by5/who_procurementlist/en/.
30. Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS, June 2005. Available at: http://www.who.int/3by5/amds/ diagnostics/en/.
31. Untangling the Web of Price Reductions: A Price Guide for the Purchase of ARVs for Developing Countries. 6th ed. Medecins Sans Frontieres, April 19, 2004.
32. Roux P, Henley L, Cotton M, et al. and the Paediatric HIV Census Group. Burden and cost of inpatient care for HIV-positive paediatric patients - status in the Cape Town metropole during the second week of March 1999. S Afr Med J. 2000;90:1008-1011.
33. Sansom S, Anderson J, Sukalac T, et al, for the PSD Consortium. Health care utilization among perinatally HIV infected US children: 2001 v 1995. Presented at: The 26th Annual Meeting of the Society for Medical Decision Marking; 2004; Atlanta, GA.
34. Sanders G, Bayoumi A, Sundaram V, et al. Cost-effectiveness for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005; 352:570-585.
35. South Africa demographic and health survey 1998. Department of Health, Republic of South Africa.
36. Montgomery DC ed. Design and Analysis of Experiments, 3rd ed. New York, NY: John Wiley & Sons, 1991.
37. Law AM, Kelton WD eds. Simulation Modeling & Analysis, 2nd ed. New York, NY: McGraw-Hill Inc, 2000.
38. New agreements aim to make lowest-cost AIDS drugs and diagnostics available to hundreds of thousands in developing world. Health Systems Trust News 2004-04-08. Available at: http://www/hst.org.za/news/20040335.
39. Bulterys M, Fowler MG, Van Rompay KK, et al. Prevention of mother-to-child transmission of HIV-1 through breast-feeding: past, present, and future. J Infect Dis. 2004;189:2149-2153.
40. UNAIDS Reference Group. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS. 2002; 16:W1-W14.
41. Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001; 344:824-831.
42. Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344:817-823.
43. Brandeau ML, Owens DK, Sox CH, et al. Screening women of childbearing age for human immunodeficiency virus. A cost-benefit analysis. Arch Intern Med. 1992; 152:2229-2237.
44. Arya OL. Screening for syphilis, HIV and HBV at delivery. Afr Health Sci. 1995;17:31.
45. Branson BM. Point-of-care rapid tests for HIV antibodies. J Lab Med. 2003; 27(7/8):288-295.
46. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet. 1999;353:773-780.
47. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breast feeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167-1174.
48. Core health indicators 2002. WHO Statistical Information System (WHOSIS), World Health Organization. Available at: http://www3.who.int/whosis/menu.cfm.
49. Spira R, Lepage P, Msellati P, et al. Mother-to-Child HIV-1 Transmission Study Group. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Pediatrics. 1999;104:e56.